Survey on the Treatment of Anemia Using Recombinant Human Erythropoietin 2 (STAR-2)

A Study to Determine the Safety and Effectiveness of Epoetin Alfa Versus Placebo in Patients With Persistent Anemia Caused by Advanced Cancer

NCT00269984 ·Status: COMPLETED ·Phase: PHASE2

" Evaluation of Erythropoietin Therapy in Patients With End-Stage Kidney Disease on Regular Hemodialysis: Hemoglobin Outcomes, and Metabolic Syndrome as a Risk Factor for Erythropoietin Resistance "

NCT06983756 ·Status: NOT_YET_RECRUITING

Treatment of the Anemia of Myelodysplastic Syndromes by the Association of Epoetin Beta and All Trans Retinoic Acid

NCT00437450 ·Status: UNKNOWN ·Phase: PHASE2

Erythropoietin in the Treatment of Anemia After Autologous Hematopoietic Stem Cell Transplantation

NCT03010579 ·Status: UNKNOWN ·Phase: PHASE4

Study to Assess the Efficacy and Safety of HX575 in the Treatment of Chemotherapy Associated Anemia in Cancer Patients

NCT00711958 ·Status: COMPLETED ·Phase: PHASE3

A Study of Recombinant Human Erythropoietin in Anemic Cancer Patients Undergoing Chemotherapy

NCT00144482 ·Status: COMPLETED ·Phase: PHASE3

Treatment Program for Anemia in AIDS Patients

NCT00002022 ·Status: COMPLETED ·Phase: NA

STAAR-2 Clinical Study

NCT00368901 ·Status: COMPLETED ·Phase: PHASE4

Treatment of Anemia With Epoetin Beta in Low Risk Myelodysplastic Syndrome (MDS)

NCT02428686 ·Status: COMPLETED ·Phase: PHASE2

Frequent, Low-Dose Erythropoietin A Mechanistic Approach to Mitigate Adverse Cardiovascular Effects of Erythropoietin

NCT03277183 ·Status: TERMINATED ·Phase: PHASE4

A Study to Observe the Number of Patients Who Develop Pure Red Cell Aplasia (PRCA, a Rare Form of Anemia) While Receiving Epoetin Alfa or Other Recombinant Erythropoietins

NCT00211029 ·Status: COMPLETED

Erythropoietin Alfa in Elderly Subjects With Unexplained Anemia

NCT00954486 ·Status: WITHDRAWN ·Phase: NA

Observatory of the Prescription of Erythropoietin as Treatment of Anemia Induced by Chemotherapy or Allograft Conditioning Among the Patients With a Haematological Malignancy

NCT02860598 ·Status: UNKNOWN

Epoetin Alfa for the Treatment of Anemia Resulting From Chronic Lymphocytic Leukemia

NCT00270049 ·Status: COMPLETED ·Phase: PHASE2

An Observational Study to Predict the Response of Erythropoietin Treatment in Participants With Cancer Related Anemia Receiving Chemotherapy

NCT01736215 ·Status: TERMINATED

Erythropoietin Treatment in Patients With Systolic Left Ventricular Dysfunction, Mild Anemia and Normal Renal Function

NCT00418119 ·Status: UNKNOWN ·Phase: PHASE4

A Safety Study of Pentoxifylline for the Treatment of Anemia

NCT01102218 ·Status: TERMINATED ·Phase: PHASE2

Study to Monitor the Incidence of Pure Red Cell Aplasia (PRCA) and/or Antibodies to Erythropoietin Among Participants Receiving Epoetin Alfa or Another Erythropoietin

NCT00210951 ·Status: COMPLETED

An Open-label Trial to Determine Increased Red Blood Cell Production in Subjects With Anemia of Chronic Disease

NCT01846689 ·Status: UNKNOWN ·Phase: PHASE3

Effects of Early Correction of Anemia in Patients With Chronic Renal Insufficiency

NCT00312871 ·Status: TERMINATED ·Phase: PHASE4

Clinical Efficacy of Two Erythropoietin Drug in Participants With Secondary Anemia to Chronic Kidney Disease.

NCT01695759 ·Status: TERMINATED ·Phase: PHASE3

Clinical Study the Efficacy and Safety of Rh-EPO in the Treatment of Anemia in Lymphoma

NCT04910594 ·Status: UNKNOWN ·Phase: PHASE3

Search for Predictive Markers of Efficacy of ESAs in Patients With Non-myeloid Malignancies or Myelodysplastic Syndrome

NCT01546337 ·Status: TERMINATED

Can Iron Lessen Anemia Due to Cancer and Chemotherapy: A Study to Investigate the Efficacy and Safety of Injectafer®

NCT02453334 ·Status: COMPLETED ·Phase: PHASE3

Expanded Access Use of Itacitinib to Treat a Single Patient With STAT1 Gain of Function (GOF) Disease

NCT05561985 ·Status: AVAILABLE